Details
Stereochemistry | ACHIRAL |
Molecular Formula | Ti |
Molecular Weight | 47.867 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ti]
InChI
InChIKey=RTAQQCXQSZGOHL-UHFFFAOYSA-N
InChI=1S/Ti
Molecular Formula | Ti |
Molecular Weight | 47.867 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414
Curator's Comment: description was created based on several sources, including
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414
Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium, chemical formula TiO
2. When used as a pigment, it is called titanium white, Pigment White 6 (PW6), or CI 77891. Generally it is sourced from ilmenite, rutile and anatase. It has a wide range of applications, from paint to sunscreen to food coloring. When used as a food coloring, it has E number E171. World production in 2014 exceeded 9 million metric tons. Titanium dioxide has excellent ultraviolet (UV) resistant qualities and acts as a UV absorbent. In the pharmaceutical industry, titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to zinc oxide. It is also commonly used as pigment for pharmaceutical products such as gelatin capsules, tablet coatings and syrups. In the cosmetics industry, it is used in toothpaste, lipsticks, creams, ointments and powders. It can be used as an opacifier to make pigments opaque. The FDA has approved the safety of titanium dioxide for use as a colorant in food, drugs and cosmetics, including sunscreens. However, controversy exists as to the safety of titanium dioxide nanoparticles used in the cosmetics industry, for example in sunscreens. Titanium and zinc oxides may be made into the nanoparticle size (0.2-100 nanometers) to reduce the white appearance when applied topically, but retain the UV blocking properties. Recent studies suggest titanium dioxide nanoparticles may be toxic, although further research is needed.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18503414
Curator's Comment: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: ultraviolet induced damage Sources: https://www.ncbi.nlm.nih.gov/pubmed/18503257 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | ANTHELIOS 40 Approved UseUnknown Launch Date2008 |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals. | 1994 Mar |
|
Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro. | 1996 Dec |
|
Molecular and biomechanical characterization of mineralized tissue by dental pulp cells on titanium. | 2005 Jun |
|
Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. | 2008 Jan |
|
Effects of ultrafine TiO2 particles on gene expression profile in human keratinocytes without illumination: involvement of extracellular matrix and cell adhesion. | 2009 Dec 15 |
|
Role of air pollution Particulate Matter (PM(2.5)) in the occurrence of loss of heterozygosity in multiple critical regions of 3p chromosome in human epithelial lung cells (L132). | 2009 Jun 22 |
|
Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytes. | 2009 Oct 16 |
|
Inhibitor of differentiation 1 (Id1) expression attenuates the degree of TiO2-induced cytotoxicity in H1299 non-small cell lung cancer cells. | 2009 Sep 28 |
|
Activation of human neutrophils by titanium dioxide (TiO2) nanoparticles. | 2010 Apr |
|
Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. | 2010 Dec 15 |
|
Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. | 2010 Feb |
|
Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. | 2010 Jan 12 |
|
Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway. | 2010 Jun 16 |
|
Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules. | 2010 Jun 2 |
|
Cellular responses by stable and uniform ultrafine titanium dioxide particles in culture-medium dispersions when secondary particle size was 100 nm or less. | 2010 Sep |
|
Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. | 2012 Dec |
|
Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice. | 2013 |
|
Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice. | 2013 |
|
Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. | 2013 Apr 5 |
|
Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549. | 2013 Feb |
|
TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils. | 2013 Jul 31 |
|
Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. | 2013 Jun 15 |
|
Improving cytocompatibility of Co28Cr6Mo by TiO2 coating: gene expression study in human endothelial cells. | 2013 Sep 6 |
|
Sheet-type titania, but not P25, induced paraptosis accompanying apoptosis in murine alveolar macrophage cells. | 2014 Oct 1 |
Sample Use Guides
Apply evenly 15 minutes before sun exposure. Reapply as needed or after towel drying, swimming, or perspiring. Children under 6 months of age, ask a doctor.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18503414
For the in vitro studies, the stratum corneum side of the skin was in contact with either the aqueous or oily commercial dispersion of microfine TiO2 (150 μl/cm^2). The dermis side was placed onto a tissue of cellulose soaked with isotonic phosphate buffered saline (PBS) of pH 7.4. Twenty-four hours after application of the dispersion, the PBS was removed from the skin with a dry paper towel. For the in vivo studies, 2 μl cm−2 of the commercial dispersions and the different formulations were applied onto the ventral side of the forearm of a healthy female volunteer. After 45 min, any dispersion or formulation that had not penetrated the skin was also removed with a paper towel. All penetration tests were performed in triplicate.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:08:44 GMT 2023
by
admin
on
Fri Dec 15 16:08:44 GMT 2023
|
Record UNII |
D1JT611TNE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
2074 (Number of products:31)
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB35397
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
D1JT611TNE
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
m10896
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
D1JT611TNE
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
DTXSID3047764
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
1305547
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | RxNorm | ||
|
7440-32-6
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
868
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
33341
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
231-142-3
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
C95189
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
DB14160
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
23963
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
D014025
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |